Entity
Basecamp
Basecamp is an AI-based drug developer that uses artificial intelligence to discover and develop new medicines.
Why it’s in the news: It is in the news for raising $140 million in funding, which valued the company at $800 million.
Latest on Basecamp
- AI-based drug developer Basecamp valued at $800 million after $140 million funding round
Connections
4 entities linked to Basecamp across the news graph.